Refining natural killer cell-based immunotherapy
Since the introduction of imatinib for the treatment of chronic myelogenous leukemia, several oncogenic mutations have been identified in ...
Recent Advances in Medicinal Chemistry (Volume 1) - SciendoFaire un doctorat ressemble davantage à un marathon qu'à un sprint. La ligne d'arrivée semble bien loin lorsque l'on commence et c'est probablement parce ... Towards novel cancer (immuno)therapy using TRAIL and Galectin-9Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to selectively induce apoptotic cell death in various tumor cells by engaging its ... Scientific Report - IECBTRAILR Récepteur des ligands induisant l'apoptose de façon ... T. D., CHAPMAN, C., GLOGER, I. S., MURPHY, K. E., SOUTHAN, C. D. ...
Autres Cours: